Search Results

The Warburg effect, decoded Whatis the Warburg Effect? Nearly a century ago, Otto Warburg observed that many tumors avidly ferment glucose to lactate even when oxygen is plentiful—so-called aerobic glycolysis . Rather than fully oxidizing glucose in mitochondria to squeeze out maximal ATP, cancer cells divert a large fraction of glucose carbon toward rapid ATP generation and biosynthesis  (nucleotides, amino acids, lipids) needed for proliferation. Warburg originally argued this reflected “injured respiration”; modern work shows the reality is more nuanced: oncogenic signaling and the tumor microenvironment reprogram  metabolism to favor glycolysis while mitochondria remain functional and essential for anabolism and redox balance. Understanding this principal is key to cancer prevention . refp.cohlife.org PMC Science In contemporary cancer biology, metabolic reprogramming is recognized as a hallmark of malignancy. This reprogramming is not simply about energy; it’s a control system  that tunes redox state, epigenetic marks, and immune evasion. As Hanahan’s updated “Hallmarks of Cancer: New Dimensions” emphasizes, altered metabolism is intertwined with genomic instability, inflammation, and immune escape—features that collectively enable tumor progression. PubMed Why glycolysis becomes an advantage How understanding the Warburg Effect may improvie your longevity Glycolysis is fast. When coupled to high glucose uptake and lactate export (via monocarboxylate transporters), it enables cells to grow under fluctuating oxygen  and to sustain the pentose phosphate pathway and one-carbon metabolism. The acidified microenvironment created by lactate (pH ~6.3–6.9) promotes invasion, angiogenesis, and immune suppression. Lactate is not merely “waste”; it’s a signaling metabolite  that shapes gene expression (including histone lactylation ) and alters the behavior of stromal and immune cells. Clinically, our exploitation of this phenotype underpins FDG-PET , which images tumors because they often take up far more 18F-fluorodeoxyglucose than surrounding tissues. PMC+1 Nature Prevention: what the Warburg effect teaches us It is crucial to avoid over-claiming: no diet or supplement “shuts off” the Warburg effect  across cancers. That said, the phenotype highlights upstream levers— adiposity, insulin/IGF-1 signaling, and physical inactivity —that create a metabolic milieu favorable to glycolysis-dependent growth. Observational and mechanistic data connect chronic hyperinsulinemia and insulin resistance  to higher risks of several cancers; insulin acts as a growth factor and can increase glucose uptake and glycolytic flux in susceptible tissues. PMC+1 Body weight and body composition.  Excess adiposity fosters hyperinsulinemia, chronic inflammation, and altered adipokines—all of which tilt cells toward glycolytic programs and anabolic growth. Global consensus statements from the World Cancer Research Fund/AICR estimate that maintaining a healthy weight and limiting weight gain across adulthood lowers risk for multiple cancers. World Cancer Research Fund Physical activity.  Regular activity improves insulin sensitivity, reduces chronic inflammation, and enhances mitochondrial oxidative capacity—physiologic counterweights to the Warburg phenotype. Evidence syntheses and guidelines recommend 150–300 minutes/week of moderate  or 75–150 minutes/week of vigorous  activity, with more generally better; adherence is associated with lower incidence and mortality across several cancers. American Cancer Society PMC+1 Dietary pattern and carbohydrate quality.  The Warburg frame sometimes inspires extreme carbohydrate restriction; evidence for universal cancer-prevention benefit of very low-carb or ketogenic diets remains limited. More solid is the signal that dietary patterns  emphasizing fiber-rich, minimally processed foods (vegetables, fruits, legumes, whole grains) and minimizing refined starches and added sugars  improve metabolic health and may lower risk of several cancers, notably colorectal. Meta-analytic and cohort data link higher glycemic load  or poor carbohydrate quality to elevated colorectal cancer risk in some populations. PMC+1 ScienceDirect How clinicians already leverage the phenotype The Warburg effect is not just a laboratory curiosity; it has diagnostic  and therapeutic  implications. FDG-PET/CT uses tumor glycolysis to localize disease and monitor response; in parallel, a wave of investigational strategies attempts to target metabolic nodes  (glycolysis, lactate transport, redox recycling) or to recondition  the microenvironment. While these approaches are still maturing clinically, they reflect a central point: tumor metabolism is plastic  and intertwined with signaling, epigenetics, and immunity. Journal of Nuclear Medicine Nature Practical, evidence-anchored takeaways Manage insulin exposure.  Maintain a healthy waist circumference; prioritize dietary patterns that blunt post-prandial spikes (fiber-rich, minimally processed foods) and distribute carbohydrates with protein and healthy fats. For people with diabetes or prediabetes, evidence-based management (diet, exercise, medications as indicated) matters for cancer prevention as well as cardiometabolic health. PMC Move more, most days.  Accumulate at least the ACS-recommended activity minutes weekly, and reduce sedentary time. Even small increments improve insulin sensitivity and mitochondrial function, pushing cellular metabolism away from glycolysis-dominant states. American Cancer Society Think in patterns, not magic bullets.  No single food or supplement reliably “starves” cancer. Focus on patterns—weight control, fitness, high-quality carbohydrate, limited alcohol, and smoking cessation—that harmonize metabolism and reduce inflammatory tone long-term. World Cancer Research Fund Bottom line The Warburg effect captures a fundamental reprogramming that makes growth possible under stress; it also offers a lens for prevention. By improving insulin sensitivity , reducing chronic inflammation , and reinforcing mitochondrial health  through diet and physical activity, we make it harder for premalignant cells to inhabit a glycolysis-favored niche. That’s not a guarantee—but it is a principled, evidence-based way to shift risk in our favor. References (publication format with links) Warburg O. On the Origin of Cancer Cells.   Science.  1956;123(3191):309–314. https://www.science.org/doi/10.1126/science.123.3191.309   Science DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism.   Sci Adv.  2016;2(5):e1600200. https://www.science.org/doi/10.1126/sciadv.1600200   Science DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism.   Sci Adv.  2016;2(5):e1600200. (Open-access version) https://pmc.ncbi.nlm.nih.gov/articles/PMC4928883/   PMC Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation.   Cell.  2011;144(5):646–674. https://pubmed.ncbi.nlm.nih.gov/21376230/   PubMed Hanahan D. Hallmarks of Cancer: New Dimensions.   Cancer Discov.  2022;12(1):31–46. https://pubmed.ncbi.nlm.nih.gov/35022204/   PubMed Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression.   Science.  2020;368(6487):eaaw5473. https://www.science.org/doi/10.1126/science.aaw5473   Science Ippolito L, et al. Lactate: A Metabolic Driver in the Tumour Landscape.   Trends Cell Biol.  2019;29(10):748–762. https://www.sciencedirect.com/science/article/abs/pii/S0968000418302275   ScienceDirect Pérez-Tomás R, Pérez-Guillén I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment Resistance.   Cancers (Basel).  2020;12(11):3244. https://pmc.ncbi.nlm.nih.gov/articles/PMC7693872/   PMC Chen J, et al. Lactate and lactylation in cancer.   Signal Transduct Target Ther.  2025;10:??? (online). https://www.nature.com/articles/s41392-024-02082-x   Nature Kawada K, et al. Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer.   Int J Clin Oncol.  2016;21(5):898–906. https://pmc.ncbi.nlm.nih.gov/articles/PMC5120247/   PMC Salas JR, et al. Signaling Pathways That Drive 18F-FDG Accumulation in Cancer.   J Nucl Med.  2022;63(5):659–666. https://jnm.snmjournals.org/content/63/5/659   Journal of Nuclear Medicine Perry RJ, et al. Mechanistic Links between Obesity, Insulin, and Cancer.   Trends Endocrinol Metab.  2020;31(10):684–695. https://pmc.ncbi.nlm.nih.gov/articles/PMC7214048/   PMC Jee SH, et al. Obesity, Insulin Resistance and Cancer Risk.   Yonsei Med J.  2005;46(3):449–455. https://pmc.ncbi.nlm.nih.gov/articles/PMC2815827/   PMC American Cancer Society. Guideline for Diet and Physical Activity for Cancer Prevention.  Updated May 5, 2025. https://www.cancer.org/cancer/risk-prevention/diet-physical-activity/acs-guidelines-nutrition-physical-activity-cancer-prevention/guidelines.html   American Cancer Society World Cancer Research Fund/AICR. Diet, Nutrition, Physical Activity and Cancer: A Global Perspective (Third Expert Report).  2018. https://www.wcrf.org/wp-content/uploads/2024/11/Summary-of-Third-Expert-Report-2018.pdf   World Cancer Research Fund Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Nutraceutical Approaches to Lowering Insulin and Supporting Diabetes Management & Weight Elevated Insulin Puts You at High Risk for Diabetes Berberine: An AMPK Activator with Insulin-Lowering Effects Berberine, an isoquinoline alkaloid extracted from plants like Berberis vulgaris , is one of the most extensively studied natural compounds for metabolic health. Its primary mechanism involves the activation of AMP-activated protein kinase (AMPK) , often described as a “metabolic master switch.” By activating AMPK, berberine enhances glucose uptake in skeletal muscle, reduces hepatic glucose production, and improves overall insulin sensitivity. Clinical trials demonstrate that berberine can lower fasting glucose, HbA1c, and fasting insulin to an extent comparable with first-line pharmaceuticals such as metformin. Additional benefits include improvement in lipid profiles and favorable modulation of gut microbiota, both of which reduce the systemic inflammation that contributes to insulin resistance. Berberine lowers insulin and blood sugar simultaneously. Berberine 500 mg take 1 capsule twice to four times, daily Chromium Picolinate and Vanadyl Sulfate: Trace Elements Influencing Insulin Action Chromium, especially in the form of chromium picolinate, functions as a cofactor that enhances insulin receptor activity and improves intracellular signaling. Supplementation has been shown in human trials to improve glucose tolerance, lower fasting glucose, and reduce insulin resistance — though effects tend to be most pronounced in individuals with suboptimal chromium status. Vanadyl sulfate, a form of the trace mineral vanadium, mimics insulin at the receptor level and activates downstream pathways to promote glucose uptake while suppressing hepatic glucose output. Clinical studies show that vanadyl sulfate can lower blood glucose and improve insulin sensitivity in type 2 diabetes, but its long-term use is limited by safety concerns related to gastrointestinal tolerance and potential toxicity. Both agents highlight how micronutrients can intersect with cellular insulin signaling, but they should be used with medical oversight. Diabet Stat II Take 1 capsule twice daily Inositol: Restoring Second Messenger Function in Insulin Signaling Inositol, particularly myo-inositol  and D-chiro-inositol , serves as a critical second messenger in insulin signaling. When this pathway falters, tissues become less responsive to insulin, perpetuating hyperinsulinemia. Supplementation with inositol has been shown to restore proper signaling, improving insulin sensitivity and lowering both glucose and fasting insulin levels. Clinical studies in women with polycystic ovary syndrome (a condition tightly linked to insulin resistance) show improved ovulation, reduced androgen excess, and better metabolic profiles. In the broader population with metabolic syndrome or diabetes, inositol supplementation has demonstrated modest improvements in HOMA-IR, triglycerides, and HbA1c, supporting its role as a low-risk adjunct to diet and exercise. Inositol 500 mg capsules Take 2 twice daily Olive Leaf Extract: Harnessing Polyphenols for Metabolic Health Olive leaf extract, derived from Olea europaea , contains powerful polyphenols such as oleuropein and hydroxytyrosol, compounds also abundant in extra-virgin olive oil. These molecules exert antioxidant and anti-inflammatory effects but also act directly on glucose metabolism. Mechanistically, olive leaf polyphenols enhance glucose uptake in peripheral tissues, increase GLUT4 translocation, and reduce oxidative stress that impairs insulin signaling. Human trials have shown that olive leaf supplementation can lower fasting glucose and HbA1c while improving lipid profiles and reducing inflammatory markers. Because of its cardiovascular benefits and general safety, olive leaf extract is emerging as a promising complementary intervention for those at risk of or living with type 2 diabetes. References Berberine Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus.   Metabolism.  2008;57(5):712-717. PubMed Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.   J Clin Endocrinol Metab.  2008;93(7):2559-2565. PubMed Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.   Evid Based Complement Alternat Med.  2012;2012:591654. PubMed Deng Y, Zhang Q, Li Y, et al. Berberine attenuates insulin resistance by enhancing insulin signaling and AMPK pathway in high-fat diet induced obese mice.   Nutrients.  2020;12(9):2688. PubMed Lan J, Zhao Y, Dong F, et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.   J Ethnopharmacol.  2015;161:69-81. PubMed Chromium Polynicotinate & Vanadyl Sulfate Anderson RA, Bryden NA, Polansky MM, et al. Chromium supplementation of human subjects: effects on glucose, insulin, and lipids.   Metabolism.  1997;46(8):1-10. PubMed Balk EM, Tatsioni A, Lichtenstein AH, Lau J, Pittas AG. Effect of chromium supplementation on glucose metabolism and lipids: systematic review of RCTs.   Diabetes Care.  2007;30(8):2154-2163. PubMed Martin J, Vincent JB. Mineral-dependent insulin-mimetic compounds: vanadium, chromium, zinc, and selenium.   J Trace Elem Med Biol.  2007;21(1):59-65. PubMed Bal A, Singh AK. Effect of vanadium and its compounds on carbohydrate metabolism.   Endocr Pract.  2008;14(7):886-889. PubMed Waring MJ, Sanders JA. Tolerance of diabetics to oral vanadyl sulfate.   Diabetes Res Clin Pract.  1995;28(1):57-60. PubMed Inositol & Olive Leaf Extract Pintaudi B, Di Vieste G, Bonomo M. Myo-inositol may improve insulin resistance and metabolic syndrome in type 2 diabetes patients.   Int J Endocrinol.  2016;2016:9132054. PubMed Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in PCOS with D-chiro-inositol.   N Engl J Med.  1999;340(17):1314-1320. PubMed Konstantinidou V, et al. In vivo nutrigenomic effects of virgin olive oil polyphenols within the frame of the Mediterranean diet: modulation of inflammation and oxidative stress in humans.   BMC Genomics.  2010;11:253. PubMed Wainstein J, Ganz T, Boaz M, et al. Olive leaf extract improves insulin sensitivity in humans.   J Med Food.  2012;15(7):605-610. PubMed Lockyer S, Rowland I, Spencer JP, et al. Impact of phenolic-rich olive leaf extract on blood pressure, plasma lipids and inflammatory markers: randomized controlled trial.   Eur J Nutr.  2017;56(4):1421-1432. PubMed Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Migraines and Sinus Headaches can strike any time, anywhere and be a painful disruption to your day. Understanding migraine vs. sinus headache matters because the right diagnosis drives the right treatment. Below is a clear, patient-friendly  guide to tell them apart and get you closer to effective relief. What Are Migraines?  A migraine  is a neurological disorder marked by moderate to severe throbbing or pulsating head pain, often on one side, commonly accompanied by nausea and sensitivity to light and sound. Some people experience a visual or sensory "aura" before or during the attack.  Common Symptoms of Migraine vs Sinus Headache, Also Called a Sinus Migraine Typical migraine signs include throbbing pain (often unilateral), nausea and/or vomiting, photophobia (light sensitivity), and phonophobia (sound sensitivity). Nasal symptoms like a runny or stuffy nose and tearing can occur with migraine and are a major reason it's mistaken for a sinus problem.  Both sinus headaches and migraines can cause runny noses and watery eyes, making diagnosis by a qualified clinicians even more crucial to treatment. Causes and Triggers: Where "Sinus Migraine" Confusion Starts Common migraine triggers include stress, dehydration, sleep changes, skipped meals, certain foods, and hormonal fluctuations. These triggers can overlap  with allergy season or a lingering cold when nasal symptoms are also common.  Who Is at Risk? Migraines can affect anyone, but women are about three times more likely than men to experience them. Family history and certain co-existing conditions  (like anxiety, depression, and sleep disorders) also raise risk.  What Are Sinus Headaches? True sinus headaches  happen when the lining of the sinus cavities is inflamed (sinusitis), creating pressure and pain in the face and forehead. Because both conditions can involve facial pain and nasal symptoms, sinus headache vs migraine can be tricky to untangle without a careful exam.  Common Symptoms of Sinus Headache vs Migraine Sinusitis typically causes facial pressure or fullness (cheeks, forehead, between/behind the eyes), nasal congestion and discharge, postnasal drip, tooth pain, possible fever, and pain that worsens when you bend forward. These features are different from migraine's hallmark nausea and sensory sensitivities.  Underlying Causes (Allergy, Infection, Structure) Sinus inflammation can stem from viral infections, bacterial infections, allergies, or structural issues like a deviated septum or polyps. Managing allergies and nasal inflammation is often key to reducing sinus-related headaches.  How Sinus Headaches Are Diagnosed A clinician can often diagnose sinusitis  by history and exam; in some cases, nasal endoscopy or CT imaging is used - particularly for chronic or recurrent cases or when complications are suspected. Routine imaging is not recommended for uncomplicated acute sinusitis.  Key Differences Between Migraine vs Sinus Headache Pain Location and Type Migraine:  Pulsing/throbbing pain, often on one side; may spread; worsens with activity. Sinus headache:  Pressure-like, deep, constant pain over the cheeks, forehead, or bridge of the nose, often with tenderness. Accompanying Symptoms (Nausea, Congestion, Sensitivity) Migraine:  Nausea/vomiting; light and sound sensitivity; may include aura; nasal tearing/runny nose can occur. Sinus headache : Thick nasal discharge, congestion, postnasal drip, possible fever, reduced smell. Duration and Frequency Migraine:  Individual attacks often last 4-72 hours. Sinusitis-related headache:  Often persists for a week to 10 days or longer, tracking the course of the infection/inflammation. About 90% of self-diagnosed sinus headaches are actually migraines. Only a qualified doctor can make the property diagnosis. Why Misdiagnosis Is Common Migraines can trigger autonomic nasal symptoms (runny/stuffy nose, watery eyes), so it can feel like a "sinus migraine." Because both conditions can follow a cold or seasonal allergies, people (and even clinicians without a full history) may lean toward sinusitis. The American Migraine Foundation notes that about 90% of self-diagnosed sinus headaches are actually migraines.  How to Get an Accurate Diagnosis Importance of Medical Evaluation If you frequently get "sinus" pain plus nausea or light/sound sensitivity - or if over-the-counter decongestants never seem to help-ask your clinician to consider migraine vs sinus headache. A targeted history (triggers, family history, aura, disability level) and focused exam are usually enough to distinguish the two.  Role of Imaging and Testing For uncomplicated acute sinusitis, routine imaging isn't recommended; clinicians reserve CT or endoscopy for recurrent/chronic cases, atypical features, or suspected complications. Conversely, most people with stable, typical migraine don't need brain imaging. Treatment Options: Sinus Headache vs Migraine Treatments for Migraines Acute relief: NSAIDs or acetaminophen at onset; prescription triptans; some may use gepants (CGRP receptor antagonists) or ditans under clinician guidance. Ditans and gepants are n ew migraine treatments  that differ slightly from existing therapies. These new medications provide additional options for people with migraine for whom other medications may be at risk of side effects. Preventive options:  CGRP monoclonal antibodies, beta-blockers, topiramate, certain antidepressants, and onabotulinumtoxinA (Botox) for chronic migraine. Lifestyle support :  Sleep regularity, hydration, stress management, trigger tracking. Treatments for Sinus Headaches Self-care & s ymptom relief : Nasal saline irrigation, intranasal corticosteroid sprays, humidification, and cautious short-term use of decongestant sprays (avoid more than 3-5 days). When antibiotics help:  Many acute sinus infections are viral and resolve on their own; clinicians may consider antibiotics for uncomplicated acute bacterial sinusitis after watchful waiting or when specific criteria are met. Chronic or recurrent cases: Evaluate for allergies or structural contributors; ENT referral and, rarely, surgery may be considered. When to See a Specialist (Headache or Sinus Care) Your "sinus headaches" come with nausea/vomiting or light/sound sensitivity. Headaches last 4-72 hours and keep returning despite "sinus" treatments.  You have chronic congestion, facial pain, or infections that persist beyond 10-14 days or keep recurring.  Any red flags (sudden "worst headache," new neurological symptoms, stiff neck, high fever, vision changes) require urgent care. If you're tired of guessing between sinus headache vs migraine, our team can help you pin down the cause and build a plan that works-whether that means modern migraine care, targeted sinus treatment, or both. Schedule a thorough evaluation  at the Stages of Life Medical Institute. David S. Klein, MD, FACA, FACPM For information in becoming a patient, follow this link.

Occipital Neuralgia results from a nerve entrapment at the upper part of the neck. At Stages of Life Medical Institute , we meet patients every week who come to us with a puzzling and debilitating pain that starts at the base of the skull and radiates upward into the scalp or even behind the eye. This condition, called occipital neuralgia , is often mistaken for migraine or tension headache—but it has its own causes, diagnostic criteria, and effective treatments. Often confused with migraine, Greater Occipital Neuralgia is caused by mechanical irritation, compression or damage to the delicate nerves that run from the base of the skull through the posterior, supportive muscles of the neck. The confusion with migraine begins with the overlap of symptoms between the two conditions, including intense pain, nausea, and eye pain. Our goal is to first diagnose your condition with precision , and offer targeted therapies that restore quality of life while avoiding unnecessary interventions. The occipital nerves run below the scalp and are easily damaged by being pinched by the muscles of the neck and may be crushed against the bone of the skull. What is Occipital Neuralgia? Occipital neuralgia is a common medical condition that arises when the greater, lesser, or third occipital nerves —which carry sensation from the upper neck and back of the head—become compressed or irritated. Patients often describe: Sharp, stabbing, “electric” jabs of pain  lasting seconds to minutes. A dull, lingering ache  between flares. Tenderness  along the nerve’s path, often just below the skull. Sensitivity to touch —even a pillow or a hat can trigger pain. Why Does Occipital Neuralgia Happen? The occipital nerves can be pinched as they weave through muscles and connective tissue in the neck. Common culprits include: Postural strain (long hours at a computer, poor ergonomics). Whiplash injuries, extension or rotational injuries of the head and neck. Arthritis of the upper cervical spine (C2–C3). Postsurgical scarring or muscular tightness. Blunt trauma We must differentiate greater occipital neuralgia from trigeminal neuralgia and other causes of occipital headache How We Diagnose at Stages of Life Our evaluation begins with a detailed history and hands-on examination . We look for hallmark signs such as nerve tenderness and pain triggered by light touch. When the story and exam point toward occipital neuralgia, we first place the patient on anti-inflammatory medications, selected muscle relaxants and membrane stabilizing medications. We select from a variety of prescription and non-prescripotion choices, depending entirely on the clinical situation. More times than not, this provides substantial relief. If necessary, we may decide to perform a diagnostic nerve block —injecting a small amount of numbing medicine around the nerve. Immediate relief confirms the diagnosis. Sometimes we repeat the block to eliminate false positives. We also rule out mimics like migraine or cervicogenic headache, using imaging or further testing, only if there are red flags. Treatment Options for Greater Occipital Neuralgia: Stepwise and Targeted At Stages of Life, our philosophy is to start simple, then step up only as needed : Lifestyle & Conservative Measures: Posture correction, ergonomic coaching, gentle neck rehabilitation, and sleep optimization. Medications: Neuropathic agents (gabapentin, tricyclics) and nonsteroidal anti-inflammatories can help some patients. Occipital Nerve Blocks: Both diagnostic and therapeutic, these injections often provide immediate relief. With ultrasound guidance, we maximize precision and safety. Our Patient Journey When you walk into Stages of Life Medical Institute , you can expect: A thorough evaluation by a board-certified physician. Clear explanations and reassurance. Tailored treatment—starting with conservative steps and progressing to advanced interventions only when necessary. Our services are performed in the office setting, minimizing collateral costs to the patient, we are located conveniently in our own office building with substantial available parking, close by. Our integrative approach means that whether you need lifestyle coaching, targeted injections, or state-of-the-art neuromodulation, your care is anchored in compassion, precision, and science. References: Headache Classification Committee of the International Headache Society. “ 13.4 Occipital neuralgia .” ICHD-3 (2018).   ichd-3.org   ICHD-3 Djavaherian DM, et al. “ Occipital Neuralgia .” StatPearls  (updated 2023). NCBI Bookshelf   NCBI Austin M, et al. “ Occipital Nerve Block .” StatPearls  (updated 2023). NCBI Bookshelf   NCBI Shim JH, et al. “ Ultrasound-guided greater occipital nerve block .” Korean J Anesthesiol  2011. PMC   PMC Barmherzig R, Kingston W. “ Occipital Neuralgia and Cervicogenic Headache: Diagnosis and Management .” Curr Neurol Neurosci Rep  2019. PDF   painschoolinternational.com Scherer SS, et al. “ The Greater Occipital Nerve and Obliquus Capitis Inferior .” Plast Reconstr Surg  2019. Journal site  Lippincott Journals Sağlam L, et al. “ Morphological features of the greater occipital nerve and its muscular relations .” Surg Radiol Anat  2023. PMC   PMC Kim HS, et al. “ Stereotactic topography of the greater and third occipital nerves .” Sci Rep  2018. Nature   Nature Juškys R, et al. “ Effectiveness of treatment of occipital neuralgia using occipital nerve block .” Medicina (Kaunas)  2018. PMC   PMC Batistaki C, et al. “ Pulsed Radiofrequency of the Occipital Nerves .” Pain Res Manag  2021. PMC   PMC De Oliveira K, et al. “ Pulsed Radiofrequency Neuromodulation of the Greater Occipital Nerve: Systematic Review .” Can J Pain  2024. Taylor & Francis   Taylor & Francis Online Manolitsis N, Elahi F. “ Pulsed Radiofrequency for Occipital Neuralgia: Review .” Pain Physician  2014. PDF   Pain Physician Journal Montenegro MM, et al. “ Long-term outcomes of occipital nerve stimulation .” Headache  2023. PMC   PMC Lam KHS, et al. “ Ultrasound-guided hydrodissection with 5% dextrose for occipital neuralgia .” Diagnostics  2024. MDPI   MDPI Ruberto N, et al. “ Percutaneous peripheral nerve stimulation for occipital neuralgia (case report) .” Orthopedic Reviews  2025. Open Medical Publishing   Orthopedic Reviews Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Alzheimer's disease affects millions worldwide, leading to profound cognitive decline and memory loss. As researchers seek effective treatments, lithium—traditionally prescribed for bipolar disorder—has gained attention as a potential ally in the battle against Alzheimer's. This blog post will explore the latest insights into the benefits of lithium and its role in Alzheimer's treatment, outline future directions for research in this critical area. Low dose lithium has demonstrating remarkable promise in the prevention and treatment of Alzheimer's disease and Memory Loss. Complex Problems frequently have Complex Solutions Understanding the Benefits of Lithium's Mechanism of Action in Preventing Alzheimer's Dementia Lithium is commonly recognized for its mood-stabilizing effects, but it also exhibits neuroprotective properties relevant to Alzheimer's disease. Research indicates that lithium may inhibit the formation of amyloid-beta plaques and tau tangles, which are key contributors to Alzheimer's pathology. Specifically, lithium's ability to inhibit glycogen synthase kinase 3 (GSK-3) can promote neuron survival and bolster neurogenesis. This action not only helps to preserve cognitive function but also suggests a promising therapeutic path for Alzheimer's patients. Why would lithium affect Alzheimer’s at all? Lithium influences several cellular pathways tied to Alzheimer’s biology. In lab and early clinical studies, lithium appears to dampen an enzyme called GSK-3β   (which helps add phosphate groups to tau), support autophagy  (the brain’s “cleanup” system for misfolded proteins such as amyloid-β), and promote nerve-growth signals like BDNF  that support synapses. These mechanisms map onto the two hallmark pathologies of Alzheimer’s—amyloid plaques and tau tangles—and to synaptic resilience. Lithium Chelate 10 mg per capsules per bottle of 60. Recent Research Findings Recent clinical trials have shed light on lithium's potential effectiveness in treating Alzheimer's disease. A significant study published in Alzheimer's & Dementia highlighted that low-dose lithium treatment led to a 25% reduction in the rate of cognitive decline in patients with mild to moderate Alzheimer's compared to a placebo group. Patients receiving lithium showed improved scores on standardized cognitive assessments, underscoring that lithium may not only stabilize mood but also enhance cognitive function. This dual impact makes lithium an exciting option for treatment. The latest headline: lithium may be biologically low  in early memory loss A 2025 Nature  study offers a unifying clue: when scientists examined human brain tissue, lithium was the only trace metal consistently reduced in people with mild cognitive impairment , and it was further bound up and “trapped” by amyloid in Alzheimer’s. In aging mice, restoring small amounts of lithium (in forms that avoid plaque binding) reversed memory decline and molecular aging signatures. This doesn’t prove benefit in humans—but it explains why lithium could be protective and strengthens the case for clinical trials. Safety and Tolerability While lithium shows promise as a treatment for Alzheimer's, safety and tolerability are paramount concerns. Lithium's side effects, particularly renal and thyroid complications, are well-documented. Yet, recent studies suggest that low-dose lithium may be effectively tolerated, especially with appropriate monitoring. Regular blood tests can help maintain lithium levels within a safe therapeutic range, minimizing the risk of adverse effects. For instance, monitoring can prevent complications in approximately 90% of patients when conducted regularly. Future Directions in Research As research interest in lithium expands, several promising areas for future investigation have emerged: Long-term Studies : To fully understand lithium's impact on cognitive decline and brain health, long-term studies tracking patients over several years are necessary. Combination Therapies : Exploring the potential synergy of lithium with other treatments could enhance its overall effectiveness. For example, research indicates that pairing lithium with certain anti-inflammatory medications could improve neuroprotection and cognitive function. Biomarker Development : Developing biomarkers to predict patient responses to lithium treatment would enable personalized therapy plans, ensuring more effective outcomes and reduced risks. Mechanistic Studies : Investigating the molecular mechanisms through which lithium exerts its neuroprotective effects could provide a deeper understanding of its interaction with Alzheimer's pathology. Research laboratory focused on Alzheimer's studies Implications for Patients and Caregivers The potential for lithium as a treatment option presents both hope and challenges for patients and caregivers. Current research offers a glimpse into its ability to slow cognitive decline, an important aspect in an area where effective treatment options are limited. Caregivers and patients should stay updated on emerging research and collaborate with healthcare professionals about potential treatment paths. Engaging with ongoing studies can help navigate the evolving landscape of Alzheimer's treatment and improve management strategies for this complex condition. What do meta-analyses say? Synthesis papers through 2024 suggest a possible reduction in dementia risk  or delayed onset among lithium-exposed individuals, while emphasizing heterogeneity and the urgent need for larger, long-duration randomized trials. Some recent meta-analyses are cautiously positive; others find no clear association  yet—reminding us not to over-interpret small trials. Dosing context: from “micro” to “standard”—and why supervision matters Research has explored three broad territories: Microdose  (e.g., ~300 μg/day): below standard psychiatric dosing; trials report no expected rise  in serum lithium and favorable tolerability, but replication is needed. Low pharmaceutical dose  (e.g., 150–450 mg lithium carbonate/day), aiming for serum ~0.2–0.5 mEq/L  in some protocols; this is where MCI biomarker and cognitive signals have appeared. Standard psychiatric dose  (e.g., 600–1200 mg/day; serum 0.6–1.0 mEq/L ): well established for bipolar disorder, but not routinely used for Alzheimer’s due to side-effect risks and lack of proven superiority in AD. (Illustration 3 is a quick visual guide; it is not  a dosing recommendation.)   NOTE: The Dosages used in this office fall well below the 'Low pharmaceutical dose, ranging from Lithium 10 mg twice a day, to as much as 20 mg twice a day. Moving Forward Lithium's evolving role in treating Alzheimer's disease signifies an exciting narrative in medical research. With unique mechanisms and emerging evidence of efficacy, lithium could become an essential tool in addressing the challenges posed by Alzheimer's. As research progresses, remaining informed about the latest findings is crucial for patients, caregivers, and healthcare providers alike. By fostering collaboration and supporting ongoing studies, we can explore innovative treatments that may one day reshape Alzheimer's care. In the search for effective therapies, lithium shines as a beacon of hope, guiding us closer to better management and comprehension of this complex disease. Safety first: who should not  self-experiment with lithium Lithium can interact with common medications ( ACE inhibitors/ARBs, thiazide and loop diuretics, NSAIDs ) and requires periodic checks of kidney function, thyroid, and serum lithium   when used at pharmaceutical doses. Dehydration and sudden changes in salt intake can raise lithium levels. Even “low-dose” strategies should be individualized and monitored. (These are general principles from geriatric lithium practice; decisions must be clinician-guided.) Where the field is headed The 2025 Nature work sets the stage for mechanism-driven human trials  that test whether carefully formulated, low-dose lithium can prevent  progression from MCI to Alzheimer’s or slow decline in early Alzheimer’s—ideally with biomarker endpoints (tau phosphorylation, amyloid dynamics, neuroinflammation) and rigorous safety monitoring. Several clinical trials are already registered to explore preventive and symptomatic roles. References (selected, accessible) Aron L, et al.   Lithium deficiency and the onset of Alzheimer’s disease.   Nature.  2025. (Mechanistic human tissue + mouse rescue study demonstrating brain lithium depletion in MCI/AD and reversal of aging phenotypes with low-dose lithium in mice.) Nature Forlenza OV, et al.   Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomized controlled trial.   Br J Psychiatry.  2011. (Reduced CSF p-tau; cognitive stabilization with low pharmaceutical dosing.) Cambridge University Press & Assessment Forlenza OV, et al.   Clinical and biological effects of long-term lithium treatment in older adults with amnestic MCI: randomized clinical trial.   Br J Psychiatry.  2019. (Longer-term cognitive stability and CSF Aβ1-42 increase.) PubMed Nunes MA, et al.   Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer’s disease.   Curr Alzheimer Res.  2013. (15-month double-blind RCT; 300 μg/day stabilized MMSE vs. placebo.) PubMed Lu Q, et al.   Lithium therapy’s potential to lower dementia risk and postpone onset: meta-analysis.   Dement Geriatr Cogn Disord.  2024. (Suggests risk reduction with exposure; underscores need for trials.) PubMed Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

As a physician, I am frequently asked about effective strategies to prevent and manage osteoporosis outside of prescription medication. While pharmacologic interventions are crucial for advanced cases, the importance of foundational nutrition cannot be overstated. Three nutrients— vitamin D3, vitamin K2, and strontium —emerge as particularly valuable in both prevention and adjunctive treatment of osteoporosis. Together, they form a triad that supports calcium utilization, bone formation, and skeletal resilience. Osteoporosis need not be an expectation of aging Vitamin D3: The Foundation of Calcium Metabolism Vitamin D3 (cholecalciferol) is indispensable for calcium absorption and bone mineralization. Its role extends beyond the gut, influencing muscle function and reducing fall risk, both of which are crucial for fracture prevention. Deficiency is widespread  in older adults, those with limited sun exposure, and individuals with chronic diseases. Clinical studies  show that maintaining sufficient vitamin D levels reduces fractures and supports musculoskeletal strength. Target blood levels : A 25-hydroxyvitamin D concentration between 40–60 ng/mL is generally considered optimal for bone protection. Vitamin K2: The Director of Calcium Placement Vitamin K2, particularly in its MK-7 form, regulates calcium distribution. It activates osteocalcin, allowing calcium to bind within bone, and matrix Gla-protein, which inhibits arterial calcification. Without K2 , supplemental vitamin D and calcium may inadvertently promote vascular calcification. Japanese and European studies  have demonstrated reductions in vertebral fractures and improvements in bone mineral density (BMD) with K2 supplementation. Practical guidance : 100–200 mcg/day of vitamin K2 MK-7 is often recommended for optimal calcium metabolism. Strontium: A Unique Bone-Strengthening Mineral Strontium mimics calcium but exerts a dual mechanism—stimulating bone formation while reducing resorption. This contrasts with most osteoporosis therapies, which tend to focus on only one side of the remodeling process. Strontium ranelate , studied extensively in Europe, has been shown to reduce both vertebral and non-vertebral fractures. Strontium citrate , available as a supplement, provides a non-pharmaceutical option for patients seeking nutritional support for bone health. Absorption considerations : It should be taken separately from calcium to avoid competition in the gut. Synergistic Benefits When combined, these three nutrients work in harmony: Vitamin D3  enhances calcium absorption. Vitamin K2  ensures calcium is deposited into bone rather than arteries. Strontium  strengthens bone by building its microarchitecture and improving density. This synergistic action addresses both the quantity  and quality  of bone, making fractures less likely. Chelated Strontium. 300 mg capsules Clinical Perspective Incorporating vitamin D3, K2, and strontium alongside adequate dietary calcium, weight-bearing exercise, and lifestyle interventions (smoking cessation, alcohol moderation) offers a robust, holistic approach to bone health. For high-risk patients, these nutrients can complement pharmacologic treatments, potentially improving outcomes. Vitamin D-3 5,000 IU with Vitamin K-2 1,000 mcg and Vitamin K-1 1,000 mg 60 capsules Conclusion Osteoporosis should not be viewed as an unavoidable consequence of aging. By strategically employing vitamin D3, vitamin K2, and strontium , we can not only prevent bone loss but also actively enhance skeletal resilience. These supplements represent a safe, evidence-based foundation for both prevention and adjunctive therapy in osteoporosis management. References Holick MF. Vitamin D deficiency. N Engl J Med . 2007;357(3):266–281. Bischoff-Ferrari HA, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomized controlled trials. BMJ . 2009;339:b3692. Dawson-Hughes B, et al. Estimates of optimal vitamin D status. Osteoporos Int . 2005;16(7):713–716. Kaneki M, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2. J Nutr . 2001;131(6):1832–1836. Cockayne S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med . 2006;166(12):1256–1261. Iwamoto J, et al. Vitamin K2 therapy for postmenopausal osteoporosis. Nutrients . 2014;6(5):1971–1980. Reginster JY, et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab . 2005;90(5):2816–2822. Meunier PJ, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med . 2004;350(5):459–468. Rizzoli R, et al. The role of strontium ranelate in the prevention and treatment of osteoporosis. Ther Adv Musculoskelet Dis . 2010;2(6):321–329. Knapen MHJ, et al. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int . 2013;24(9):2499–2507. Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM make an appointment, click this link David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Uric Acid is a Metabolic Waste Product that Causes Remarkable Damage, even in Modest Levels in Your Blood For decades, elevated serum uric acid (SUA) was primarily associated with gout and nephrolithiasis . However, mounting evidence has reframed hyperuricemia as a pathophysiological contributor to a broader array of diseases, particularly those involving the cardiovascular and renal systems. Elevated SUA is now implicated in the pathogenesis and progression of atherosclerosis, hypertension, heart failure, atrial fibrillation (AF), aneurysmal disease, and chronic kidney disease (CKD) . This blog explores the emerging literature linking hyperuricemia with four major complications: heart disease, aneurysms, atrial fibrillation, and kidney failure . 1. Uric Acid as a Vascular Toxin Uric acid, the final oxidation product of purine metabolism, is pro-oxidant under physiological conditions. It enters endothelial and vascular smooth muscle cells via specific transporters (e.g., URAT1, GLUT9), where it triggers intracellular oxidative stress, reduces nitric oxide bioavailability, and induces inflammation via NF-κB activation. These events collectively promote endothelial dysfunction, a precursor to most forms of cardiovascular pathology. 2. Uric Acid and Atherosclerotic Heart Disease, Atrial Fibrillation and Valvular disease. Elevated SUA correlates with increased risk of ischemic heart disease , independent of classical risk factors. The pathophysiologic mechanisms include vascular smooth muscle proliferation, foam cell formation, and heightened platelet aggregation. Moreover, uric acid has been shown to promote coronary artery calcification and arterial stiffness. In a large prospective cohort study, hyperuricemia was found to be a predictive marker of myocardial infarction and cardiovascular mortality , even among individuals with normal renal function and without gout. 3. Uric Acid and Aneurysm Formation Hyperuricemia has been associated with abdominal aortic aneurysms (AAAs)  through mechanisms involving matrix metalloproteinase activation, increased oxidative stress, and vascular inflammation. Animal studies demonstrate that uric acid exacerbates elastin degradation and adventitial inflammation in the aortic wall, accelerating aneurysmal dilation. Clinically, higher uric acid levels have been reported in patients with AAA compared to matched controls, suggesting a biomarker or mechanistic role. 4. Uric Acid and Atrial Fibrillation There is increasing recognition that elevated SUA is an independent risk factor for atrial fibrillation, especially in the elderly. Uric acid contributes to atrial remodeling by enhancing oxidative injury, promoting fibrosis via TGF-β signaling, and stimulating atrial myocyte apoptosis. Large epidemiological studies, including the Framingham Heart Study, have shown a dose-dependent relationship between SUA and incident AF, even after adjusting for renal function, hypertension, and metabolic syndrome. 5. Uric Acid and Chronic Kidney Disease (CKD) The kidney is both the source and the target of uric acid’s pathogenicity. Uric acid induces afferent arteriolar vasoconstriction , glomerular hypertension, and tubulointerstitial fibrosis. It also inhibits endothelial nitric oxide synthase, worsening renal perfusion. Longitudinal studies have shown that hyperuricemia is not merely a marker but a causal mediator  of CKD progression. Uric acid-lowering therapy has been shown to slow eGFR decline in multiple interventional trials. 6. Therapeutic Implications While the use of uric acid-lowering therapy (ULT) such as allopurinol or febuxostat has been traditionally confined to gout management, emerging trials suggest pleiotropic benefits  in cardiovascular and renal outcomes. The FEATHER and FREED studies demonstrated renal protection in hyperuricemic patients with CKD stages 3–4, while the CARES trial illuminated the cardiovascular risk-benefit profile of febuxostat. Dietary interventions (low-purine, reduced fructose intake), weight loss, and pharmacologic ULT may serve as effective strategies to modulate serum uric acid and reduce downstream morbidity. Conclusion Uric acid is no longer a passive metabolic byproduct but an active player in cardiovascular and renal disease pathogenesis . Screening for and addressing hyperuricemia—particularly in patients with comorbid hypertension, CKD, or metabolic syndrome—may represent an underutilized strategy in risk mitigation. Given the accumulating evidence, it is prudent to view uric acid not just as a marker but as a modifiable risk factor  for systemic disease. Controlling this problem is as easy as taking a single Allopurinol tablet per day, Uloric tablet, or using the over the counter product, Uric Acid Balance. At the very least, get your uric acid level checked when you get your routine blood work. More to come. I will be doing a post on the relationship between Uric Acid and Atrial Fibrillation in greater detail. This is a game-changer. An over the counter alternative to Allopurinol and/or Uloric prescription References Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med . 2008;359(17):1811–1821. Borghi C, Agabiti-Rosei E, Johnson RJ, et al. Hyperuricemia and gout in cardiovascular, metabolic and kidney disease. Eur J Intern Med . 2020;80:1–11. Kuwabara M, Niwa K, Nishi Y, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res . 2014;37(8):785–789. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol . 2001;87(12):1411–1414. Zhang W, Iso H, Ohira T, et al. Serum uric acid and risk of cardiovascular mortality: the Japan Collaborative Cohort Study. J Atheroscler Thromb . 2016;23(8):692–703. Kivity S, Kopel E, Maor E, et al. Association of serum uric acid and cardiovascular disease: a 20-year follow-up study. J Clin Hypertens . 2013;15(1):51–57. Battelli MG, Bortolotti M, Polito L, et al. The role of xanthine oxidoreductase and uric acid in metabolic syndrome. Biochim Biophys Acta . 2015;1851(1):96–104. Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang D-H. Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens . 2010;28(6):1234–1242. Wen Y, Xu J, Ma X, et al. Serum uric acid levels and the prevalence of abdominal aortic aneurysm in Chinese patients. Clin Chim Acta . 2018;482:100–105. Domienik-Karłowicz J, Stępień A, Rostoff P, et al. Serum uric acid levels and abdominal aortic aneurysm expansion. Angiology . 2022;73(2):174–180. Tamariz L, Agarwal S, Soliman EZ, et al. Uric acid as a predictor of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Heart Rhythm . 2011;8(8):1160–1166. Kuwabara M, Niwa K, Ohtahara A, et al. Hyperuricemia is an independent risk factor for atrial fibrillation in Japanese hypertensive patients. Hypertens Res . 2012;35(6):739–743. Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta . 2018;484:150–163. Kanbay M, Segal M, Afsar B, et al. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart . 2013;99(11):759–766. Obermayr RP, Temml C, Gutjahr G, et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol . 2008;19(12):2407–2413. Jalal DI, Chonchol M, Chen W, Targher G. Uric acid as a target of therapy in CKD. Am J Kidney Dis . 2013;61(1):134–146. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis . 2006;47(1):51–59. Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum . 2009;61(7):885–892. Kojima S, Sakamoto T, Ishihara M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol . 2005;96(4):489–495. White WB, Saag KG, Becker MA, et al. Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med . 2018;378(13):1200–1210. Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Atrial fibrillation (AF) is a common form of irregular heartbeat that can lead to severe complications, including stroke and heart failure. While many factors contribute to the risk of developing AF, the role of elevated uric acid levels in the blood is an area that has gained relatively little attention . However, emerging research suggests that uric acid levels may significantly influence the onset of atrial fibrillation. Uric acid, a product of purine metabolism, is usually linked to gout and other metabolic disorders. Recent studies indicate a growing recognition of its importance in cardiovascular health, particularly regarding atrial fibrillation. This post will explore the complex connection between uric acid levels and atrial fibrillation, examining mechanisms, clinical findings, and future directions for research. The relationship between elevated serum uric acid (SUA) levels and atrial fibrillation (AF) has become an area of increasing interest in cardiovascular research. While uric acid is traditionally associated with gout and renal calculi, accumulating evidence suggests it plays a broader pathophysiological role as a pro-oxidant, inflammatory mediator, and endothelial disruptor—all of which are pertinent to arrhythmogenesis. Note Well: The issues with Atrial Fibrillation begin at levels far below those necessarily seen with kidney stones and gout. That is, damage to the heart, kidneys and blood vessels begins long before the obvious chemical changes may be detected. In fact, nearly 3/4 of the population is at risk. " Compared with the lowest uric acid quartile, each of the upper 3 quartiles were associated with an increased risk of AF in a dose–response manner." (reference 1) To mainstream medicine, this is an absolute game-changer. Uric acid levels, once considered useful for gout, alone, will now be used far more widely as a screening tool. for Atrial Fibrillation risk. Understanding Uric Acid and its Sources Uric acid is produced when the body breaks down purines—substances found in foods like red meats, organ meats, and certain seafood. Under normal conditions, uric acid is excreted through urine. However, if levels get too high, it can lead to hyperuricemia and health issues like gout . Certain foods can elevate uric acid levels. For example, consuming 100 grams of red meat can significantly impact uric acid production. Beverages sweetened with fructose, like sugary sodas, have been shown to increase uric acid levels by more than 50% in some studies. People who are predisposed to high uric acid should monitor their diets closely. Chronic medical conditions can also raise uric acid levels. Obesity, for instance, affects how the body excretes uric acid, with studies showing that individuals with a body mass index (BMI) over 30 have a higher risk of developing hyperuricemia. The Link Between Uric Acid and Atrial Fibrillation. The Risk of AF and Uric Acid Levels Research has increasingly pointed to a link between high uric acid levels and the risk of atrial fibrillation. Elevated uric acid levels may influence AF through several pathways. One proposed mechanism involves inflammation. High uric acid levels can act as inflammatory mediators, causing oxidative stress. This oxidative stress may damage heart tissue and contribute to structural changes in the atrial chambers, paving the way for AF. In fact, studies have suggested that patients with elevated uric acid have a 30% higher risk of developing AF compared to those with normal levels. Additionally, hyperuricemia often coexists with other cardiovascular risk factors such as high blood pressure and diabetes. These combined risks create an environment conducive to the development of AF, emphasizing the need to manage uric acid levels to improve overall heart health. Pathophysiological Overview Uric acid, the final product of purine metabolism, has been implicated in various mechanisms that predispose to AF: Oxidative Stress : Elevated uric acid generates reactive oxygen species (ROS), primarily through xanthine oxidase activity, which damages cardiomyocytes and fosters an arrhythmogenic substrate. Inflammation : Hyperuricemia promotes the release of pro-inflammatory cytokines (e.g., IL-6, TNF-α, CRP), which contribute to atrial remodeling and fibrosis. Endothelial Dysfunction : Uric acid reduces nitric oxide availability, disrupting vasodilation and enhancing systemic hypertension, a major AF risk factor. Electrical Remodeling : Experimental studies suggest that uric acid may interfere with ion channel expression or function, promoting atrial ectopy. Clinical Evidence Supporting the Connection Multiple clinical studies provide compelling evidence linking uric acid levels to atrial fibrillation risk. A large cohort study involving over 5,000 participants found that those with hyperuricemia had a 25% increased incidence of AF compared to their peers with normal levels. Another meta-analysis encompassing various demographics established a consistent association, showing that elevated uric acid levels were linked to a 40% increased occurrence rate of AF. Recognizing uric acid as a modifiable risk factor is vital. Regular monitoring can help identify patients at risk, enabling early intervention strategies focused on lowering uric acid levels and thereby potentially reducing AF risk. Gender and Comorbidity Modifiers Sex-specific differences have been observed, with some data suggesting a stronger association in women. Moreover, hyperuricemia seems to exacerbate AF risk particularly in those with heart failure, obesity, or insulin resistance, highlighting the multifactorial nature of uric acid’s role in cardiovascular pathology. The Importance of Lifestyle Modifications Given the connection between high uric acid and atrial fibrillation, adopting lifestyle changes is essential to manage and lower uric acid levels. Here are some actionable recommendations: Dietary Adjustments Reduce Purine Intake: Cutting back on foods high in purines—like red meat, organ meats, and certain seafood—can lower uric acid levels. Studies indicate that a diet rich in fruits, vegetables, whole grains, and low-fat dairy may help maintain healthy uric acid levels. Stay Hydrated: Drinking adequate amounts of water supports kidney function, helping the body excrete uric acid effectively. Aim for at least 2-3 liters of water daily. Limit Fructose and Alcohol: Reducing sugary beverages and limiting alcohol, especially beer, can help decrease uric acid production. Research shows that even reducing one sugary drink per day can significantly lower uric acid levels over time. Weight Management Achieving and maintaining a healthy weight is crucial. Research indicates that losing just 5-10% of body weight can lead to significant reductions in uric acid levels. Incorporating regular physical activity not only aids in weight control but also improves overall cardiovascular health. A balanced diet rich in vegetables and lean proteins can help manage uric acid levels. The Role of Medication in Managing Uric Acid Levels For some individuals, lifestyle modifications alone may not be enough to control uric acid levels. In these cases, healthcare providers might recommend medications such as allopurinol and febuxostat. These medications can effectively lower uric acid levels, which may also reduce the risk of atrial fibrillation, particularly in patients who have recurrent AF. While these treatments can be beneficial, they should always be administered under the guidance of a healthcare professional to ensure safe and effective use. The Future of Research on Uric Acid and Atrial Fibrillation The relationship between high uric acid levels and atrial fibrillation represents an important area of research with significant implications for clinical practice. Although existing studies have established a connection between hyperuricemia and AF, there is much more to learn. Future research should prioritize the following areas: Longitudinal Studies: Conduct studies that investigate the causal links between uric acid levels and AF development over time. Genetic Factors: Explore the genetic aspects of uric acid metabolism to identify high-risk individuals. Therapeutic Targets: Investigate potential new therapeutic targets based on the influence of uric acid on cardiac health. By enhancing our understanding of this connection, healthcare professionals can create more effective prevention and treatment strategies for individuals at risk. Final Thoughts on Uric Acid and Atrial Fibrillation The emerging link between elevated uric acid levels and atrial fibrillation is a critical aspect of cardiac health that warrants further examination. With strong evidence connecting hyperuricemia to an increased risk of AF, it is essential for both healthcare providers and patients to take proactive steps in managing uric acid levels. By adopting lifestyle changes, regularly monitoring uric levels, and considering medical treatments when necessary, we can significantly mitigate the risk of atrial fibrillation. As we continue to explore this intriguing connection, the ultimate goal is to enhance heart health and improve the quality of life for those at risk. It may be as easy as taking a daily dose of Allopurinol, Uloric or curated Over the Counter products. An over the counter alternative to Allopurinol and Uloric References Ding M, Nguyen-Viet N, Gigante B, LindV, et al. Elevated Uric Acid is Associated with New-Onset Atrial Fibrillation: Results from the Swedish AMRIS Cohort. JAHA 2023, 12: 122.027089 (BEST Link to original article) Kuwabara M, Hisatome I, Niwa K, et al. Uric acid is a strong risk marker for atrial fibrillation in hypertensive patients. Hypertens Res . 2010;33(9):932-938. doi:10.1038/hr.2010.105 Tamariz L, Hernandez F, Bush A, et al. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm . 2014;11(7):1102-1108. doi:10.1016/j.hrthm.2014.03.030 Nyrnes A, Toft I, Njølstad I, et al. Uric acid is associated with future atrial fibrillation: an 11-year follow-up of 6308 men and women—The Tromsø Study. Europace . 2014;16(12):1724-1730. doi:10.1093/europace/euu114 Kim YG, Han KD, Choi JI, et al. Elevated uric acid predicts incident atrial fibrillation in a large population-based cohort. Circ J . 2021;85(4):372-379. doi:10.1253/circj.CJ-20-0942 Zhang J, Xiang G, Xiang L, et al. Elevated serum uric acid levels are associated with increased risk of atrial fibrillation: a meta-analysis of observational studies. J Cardiovasc Electrophysiol . 2020;31(9):2397-2405. doi:10.1111/jce.14694 Iwashima Y, Horio T, Takami Y, et al. Relation between serum uric acid and atrial fibrillation in patients with hypertension. Am J Cardiol . 2006;98(7):1021-1026. doi:10.1016/j.amjcard.2006.04.027 Cengel A, Sahinarslan A, Tavil Y, et al. Serum uric acid levels and its association with atrial fibrillation. Anadolu Kardiyol Derg . 2008;8(2):102-105. PMID:18523579 Cai Z, Xu X, Wu J, et al. Relationship between serum uric acid levels and atrial fibrillation in the elderly. BMC Cardiovasc Disord . 2021;21(1):15. doi:10.1186/s12872-020-01807-2 Chen YH, Wang CY, Hsu CY, et al. Hyperuricemia is associated with left atrial enlargement and diastolic dysfunction in hypertensive patients. PLoS One . 2014;9(12):e115384. doi:10.1371/journal.pone.0115384 Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol . 2012;60(22):2263-2270. doi:10.1016/j.jacc.2012.04.063 Yamada H, Saito M, Fujii H, et al. Association between uric acid and atrial fibrillation in patients with chronic kidney disease. Circ J . 2012;76(3):607-613. doi:10.1253/circj.cj-11-0892 Gonzalez-Juanatey C, Pineiro R, Garcia-Acuna JM, et al. Uric acid and endothelial dysfunction in hypertensive patients. Curr Hypertens Rep . 2004;6(6):480-486. doi:10.1007/s11906-004-0020-3 Liu X, Meng Q, Zhang C, et al. Hyperuricemia as an independent risk factor for atrial fibrillation: a cross-sectional study. Clin Cardiol . 2020;43(8):856-862. doi:10.1002/clc.23395 Yu KH, Kuo CF, See LC, et al. Hyperuricemia and risk of atrial fibrillation: a nationwide population-based study. Int J Cardiol . 2016;215:321-326. doi:10.1016/j.ijcard.2016.04.122 Li Y, Chen Y, Xu J, et al. Gender-specific relationship between uric acid and atrial fibrillation in patients with diabetes mellitus. Front Cardiovasc Med . 2021;8:642667. doi:10.3389/fcvm.2021.642667 Okumura Y, Watanabe I, Kofune M, et al. Uric acid level predicts recurrence of atrial fibrillation after catheter ablation. Circ J . 2011;75(10):2495-2498. doi:10.1253/circj.cj-11-0272 Yamada T, Iwakami N, Toyama K, et al. The effect of xanthine oxidase inhibition on atrial remodeling in experimental AF models. J Cardiovasc Pharmacol . 2012;59(5):420-427. doi:10.1097/FJC.0b013e318243d041 Otaki Y, Watanabe T, Konta T, et al. Impact of hyperuricemia on the risk of atrial fibrillation: the Takahata Study. Int J Cardiol . 2013;167(6):2322-2327. doi:10.1016/j.ijcard.2012.06.130 Delles C, Gross V, Schmieder RE. Role of uric acid in endothelial dysfunction and hypertension. Curr Hypertens Rep . 2002;4(2):105-110. doi:10.1007/s11906-002-0045-4 Virdis A, Masi S, Casiglia E, et al. Endothelial function and cardiovascular disease: history and analysis of the pathophysiological basis. Br J Clin Pharmacol . 2019;85(1):35-44. doi:10.1111/bcp.13760 Professionals discussing dietary strategies to manage uric acid levels and reduce AF risk. Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

This is a very important article to understand why and where chronic disease begins and ends for an incredibly large portion of our population. Glycocalyx is a crucial yet often overlooked component of our vascular health. T his gel-like layer of glycoproteins and polysaccharides coats the inside of blood vessels and serves many important functions . As cardiovascular diseases become more common, grasping how glycocalyx works is more important than ever. The glycocalyx acts as a protective barrier against harmful agents and physical stress, regulates the exchange of substances between blood and tissues, and helps with cell communication. Studies indicate that a healthy glycocalyx can significantly influence cardiovascular health outcomes, leading to better chances of avoiding serious conditions. In short, this is where cardiac and kidney disease most frequently begins. If you've ever wondered why some people develop heart disease, without perceivable risks and seemingly, 'out of the blue,' this offers substantial insight. NOTE: This is going to get technical. It is not important that you understand the intricacies of this, but it is important that you understand the importance of the Glycocalyx. In many patients, it explains the why illness develops and supporting it can lead to disease recovery. The Structure of the Glycocalyx The glycocalyx is made up of glycoproteins, proteoglycans, and glycosaminoglycans . This complex structure creates a negatively charged surface that helps keep blood cells and proteins flowing smoothly. Recent electron micrographs show a detailed view, demonstrating how differences in its structure are linked to various health issues. Think of it as the sea grass that sits on the bottom of the lake, acting as a protective layer, maintaining the structure and keeping it defended from damage . The glycocalyx is damaged from a variety of actors, including inflammatory chemicals in the body, viruses, and bacteria. More commonly, it is damaged by small uric acid crystals and shearing forces from red blood cells, battering the inside of the blood vessel. If you protect this layer, 'hardening of the arteries,' atherosclerosis, plaque is prevented . Different areas of the body can have varying glycocalyx thickness. For example, in the heart, the glycocalyx typically measures around 1-2 micrometers thick, adapting to specific needs based on the stresses it experiences. Glycocalyx Function in Vessel Health The glycocalyx is essential for keeping endothelial cells healthy. It helps manage the transport of larger molecules and ions, which is vital for maintaining blood pressure and fluid balance. It can also sense changes in blood flow and pressure, prompting the body to adapt. When inflammation is chronic or there is excessive pressure, this balance is disrupted, leading to a breakdown of the glycocalyx layer. Glycocalyx and Inflammation Many factors can lead to an unhealthy glycocalyx, including ongoing inflammation and oxidative stress. When inflammatory substances and free radicals increase, they can damage the glycocalyx, raising the risk of cardiovascular problems. In recent research, it was found that a damaged glycocalyx correlates with a 50% increase in the adhesion of white blood cells, leading to inflammation. This heightened inflammation can promote the formation of clots, which further complicates heart health. Inflammation has a profound and deleterious effect on the endothelial glycocalyx , a critical protective layer lining the luminal surface of blood vessels. The glycocalyx is composed of glycoproteins, proteoglycans (such as syndecans and glypicans), and glycosaminoglycans (e.g., heparan sulfate, hyaluronic acid), playing a key role in vascular permeability, mechanotransduction, and anti-inflammatory signaling. The effects of inflammation on the glycocalyx include: Degradation and Shedding: Inflammatory mediators (e.g., TNF-α, IL-1β, IL-6 ) and oxidative stress (ROS, RNS) activate matrix metalloproteinases (MMPs), heparanase, and hyaluronidase , leading to the enzymatic breakdown of glycocalyx components. Shedding of syndecans and glypicans  results in loss of glycocalyx integrity, leading to increased vascular permeability and leukocyte adhesion. Increased Vascular Permeability and Edema: The glycocalyx serves as a molecular sieve , regulating fluid exchange between the blood and interstitium. Degradation of heparan sulfate and hyaluronic acid disrupts the glycocalyx’s barrier function , facilitating excessive plasma leakage and tissue edema, contributing to conditions such as ARDS and sepsis . Endothelial Dysfunction and Pro-thrombotic State: Glycocalyx degradation exposes the endothelial adhesion molecules  (e.g., ICAM-1, VCAM-1, P-selectin), promoting leukocyte adhesion and transmigration, exacerbating inflammation. Loss of antithrombotic properties (e.g., antithrombin III binding sites ) increases platelet adhesion and coagulation activation, potentially leading to disseminated intravascular coagulation (DIC)  in severe inflammatory states. Microvascular Impairment and Organ Dysfunction: The glycocalyx is critical for shear stress transduction , regulating endothelial nitric oxide (NO) production. Its degradation reduces NO bioavailability , impairing vasodilation and contributing to capillary rarefaction, microvascular ischemia, and multi-organ dysfunction . Clinical Implications: Sepsis and Critical Illness:  Glycocalyx breakdown contributes to capillary leakage, hypotension, and end-organ failure. Diabetes and Atherosclerosis:  Chronic low-grade inflammation leads to sustained glycocalyx impairment, promoting endothelial dysfunction. COVID-19 and ARDS:  SARS-CoV-2 infection induces severe glycocalyx degradation, exacerbating pulmonary microvascular permeability. Potential Therapeutic Approaches: Glycocalyx-protective strategies  include: Antioxidants (NAC, vitamin C) Heparanase inhibitors Sulodexide (glycosaminoglycan supplementation) Albumin infusion (glycocalyx stabilization) Hydrocortisone (anti-inflammatory effects with possible glycocalyx preservation) Allopurinol and similar medications that lower uric acid levels. Glycocalyx in Cardiovascular Diseases Glycocalyx damage has been observed in various cardiovascular diseases like atherosclerosis, diabetes, and hypertension. Losing this protective layer speeds up problems within blood vessels, contributing to plaque buildup. In studies, individuals with type 2 diabetes showed nearly 30% glycocalyx degradation compared to healthy individuals, which directly relates to their increased risk of heart attacks and strokes. The Role of Diabetes in Glycocalyx Alteration Diabetes can drastically change the structure and function of the glycocalyx. High blood sugar levels result in the production of substances known as advanced glycation end-products (AGEs). These compounds can harm the glycocalyx and significantly impact the health of blood vessels. Think Hemoglobin A1c elevation above 5.5 Research shows that by controlling blood sugar, we can improve glycocalyx health, highlighting potential therapies that focus on keeping this layer intact in diabetic patients. Hypertension and Its Toll on Glycocalyx High blood pressure also takes a toll on the glycocalyx, worsening its breakdown due to increased pressure and inflammation. Keeping blood pressure in check can be protective, emphasizing the importance of managing hypertension for overall vascular health. Some studies suggest that medication aimed at enhancing glycocalyx integrity may improve blood flow and vessel function. For instance, using drugs that promote glycocalyx repair could lead to a 20% improvement in vascular function for those suffering from hypertension. Therapeutic Implications Understanding the role of the glycocalyx has sparked innovative therapeutic strategies. Researchers are exploring drugs that enhance the production of glycocalyx components and help reduce its breakdown. By directly targeting the glycocalyx, treatments could lead to improved patient outcomes in conditions like heart disease, potentially reducing hospitalizations related to cardiovascular issues. This is a particularly effective mixture that is useful in the treatment of conditions that damage the inner lining of the blood vessels. The Dosage is 3 capsules daily, and I may add additional long-chain hyaluronic acid to the regimen. With the glycocalyx mend, I often add 1 Tablespoon, daily of Lubrisyn, a liquid form of hyaluronic acid. Lubrisyn is a bit sweet, and can be added to your breakfast regimen. Tak3 1 tablespoon, daily. After you open the bottle, it is best to refrigerate the open bottle. Future Directions in Glycocalyx Research Current research is focused on understanding the biochemical pathways that regulate the glycocalyx. Exploring how lifestyle choices like diet and exercise impact its health may lead to new preventative strategies against cardiovascular diseases. Identifying reliable markers for glycocalyx health could enable medical professionals to monitor and assess vascular well-being more effectively. Integrating Glycocalyx Studies into Clinical Practice Bringing glycocalyx research into everyday clinical practice is essential. Advanced imaging techniques can help evaluate glycocalyx health and align these findings with cardiovascular risk assessments. This approach could lead to more personalized treatments for patients. Continuing to promote collaboration between researchers and healthcare practitioners will help translate glycocalyx insights into real-world applications, ultimately benefiting patient care. Final Thoughts Recognizing the importance of the glycocalyx in cardiovascular health can lead to new strategies for prevention and treatment. Its role as a protective barrier demonstrates the need for maintaining its integrity. As research continues to uncover the complexities of the glycocalyx, it may become a pivotal focus in combating cardiovascular disease. Future studies will surely expand our understanding and enhance approaches to supporting vascular health. Inflammation severely disrupts the glycocalyx, leading to increased vascular permeability, endothelial dysfunction, and a pro-thrombotic state, all of which contribute to systemic pathology in conditions like sepsis, ARDS, and chronic cardiovascular disease. References Apte, S., & Dutta, P. (2022). The Role of Glycocalyx in Cardiovascular Disease. Journal of Cardiology , 45(1), 23-30. Chen, X., & Li, Y. (2023). Glycocalyx Damage in Diabetic Vascular Complications. Diabetes Care , 46(5), 999-1007. Kostousov, Y., & Nikiforov, A. (2021). Modifications of Glycocalyx in Hypertension: A New Therapeutic Target. Hypertension Research , 44(11), 1407-1414. Santos, M., & Cazal, S. (2022). Relationship Between Glycocalyx Integrity and Inflammation in Cardiovascular Disease. Atherosclerosis , 345, 24-32. Versteeg, H. H., & Weisel, J. W. (2021). The Role of Glycocalyx in Thrombosis and Hemostasis. Blood Reviews , 49, 100770. Jiao, Z., & Wang, L. (2023). Innovations in Glycocalyx Research: Implications for Cardiovascular Therapy. Cardiovascular Innovations and Applications , 17(3), 179-188. Moller, A., & Kearney, M. (2020). Glycocalyx in Acute Cardiovascular Events: Clinical Insights and Future Directions. International Journal of Cardiology , 299, 192-198. McDonald, D. E., & Wan, M. Y. (2022). The Effect of High Shear Stress on Glycocalyx Integrity in Hypertensive Patients. European Heart Journal , 43(28), 2612-2620. Liu, Q., & Yang, L. (2023). Glycocalyx: A Novel Target for Diabetes Therapy. Endocrine Reviews , 44(2), 189-200. 10. Gupta, S., & Patel, J. (2021). The Glycocalyx as a Potential Biomarker for Endothelial Function in Cardiovascular Disease. Journal of Vascular Surgery , 73(4), 1381-1389. 11. Tzeng, W. C., & Tsai, Y. J. (2022). Progress in Glycocalyx Research: Implications in Cardiac Pathology. Cardiovascular Pathology , 59, 107684. 12. Rasuli, S., & Dehdashti, F. (2023). Impact of Dietary Habits on Glycocalyx Preservation: Clinical Implications. Nutrition Reviews , 81(7), 643-654. 13. Sharma, N., & Kumar, A. (2022). Targeting Glycocalyx in the Management of Cardiovascular Disease: A Review. Journal of Clinical Medicine , 11(10), 2780. 14. Mitchell, R., & Penfold, J. (2021). The Role of Endothelial Glycocalyx in Hemodynamic Regulation. American Journal of Physiology - Heart and Circulatory Physiology , 320(6), H2335-H2345. 15. O’Brien, M. A., & Smith, S. R. (2023). Advances in Understanding the Glycocalyx and Its Clinical Relevance to Cardiovascular Disease. Circulation , 147(4), 312-320. Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

I spend an enormous amount of time with patients, far more than does the average 'medical practitioner.' Much of that time is spent trying to convince the patient that they are causing most of their medical issues through what they eat in their diet. Nobody is ever surprised, and yet it continues to be a problem. Fructose is cheap. Sucrose is cheap. Food, as a proportion of our income is far less of a relative percentage now, than at any time in human history. And yet, poor choices result in poor outcomes and we are eating ourselves to death. Before I receive the onslaught of complaints that the discussion below, is too technical, please understand that it is actually a simplification, but I present it to you in an attempt to convince you that it is very important, and not simply one of those many platitudes that one learns to expect from their well-meaning doctors. Simply stated, Fructose is more addictive than alcohol, nicotine, cocaine or heroin . Over consumption is most probably responsible directly or indirectly for more deaths than those previously mentioned poisons. Fructose, High Fructose Corn Syrup Directly Causes Arthritis Fructose, a monosaccharide prevalent in the modern diet, particularly through high-fructose corn syrup (HFCS) and sucrose, has been implicated in exacerbating inflammatory conditions such as arthritis.  Its metabolic pathways and subsequent physiological effects contribute to inflammation and various health disorders.​ Metabolic Pathways of Fructose and Inflammatory Mechanisms. Arthritis and Triglycerides Fructose cause Triglycerides elevate and available ATP to be decreased. Upon ingestion, fructose is primarily metabolized in the liver.  Unlike glucose, fructose metabolism bypasses the regulatory step catalyzed by phosphofructokinase, leading to unregulated phosphorylation by fructokinase.  This process results in the rapid depletion of adenosine triphosphate (ATP) and accumulation of AMP, which is subsequently degraded to uric acid .​ This is, in part, one of the reasons that fructose consumption can lead to hyperuricemia (elevated uric acid) which is directly related to decrease life expectancy and an increase in the incidence of non-cholesterol related atherosclerotic heart disease. For further information, there, read my blogs on Uric Acid. Pay close attention to the statistics. \ Worsening of a persons arthritis can be experienced mere hours after ingesting fructose rich foods, and the effect can last days. Improvement of arthritis symptoms can be experienced a day or two after dropping it from the diet. Fructose causes insulin resistance (metabolic syndrome, pre-diabetes) as well as kidney damage, obesity blood pressure elevation and Non Alcoholic Fatty Liver Disease Fructose elevates Uric Acid Levels, causing kidney disease and Liver disease (NAFLD) Elevated uric acid levels can induce inflammation by stimulating the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6), contributing to joint inflammation observed in arthritis. Moreover, fructose metabolism promotes de novo lipogenesis, leading to increased triglyceride synthesis and lipid accumulation.  This lipid overload can result in hepatic steatosis and the release of inflammatory mediators, further exacerbating systemic inflammation. That is, it can be the cause of 'Non Alcoholic Fatty Liver Disease (NAFLD) Fructose and Gut Dysbiosis Fructose causes gut inflammation and cardiac rhythm disorders High fructose intake has been associated with alterations in gut microbiota composition, known as dysbiosis . This imbalance can increase intestinal permeability, allowing endotoxins to enter the circulation and trigger inflammatory responses. Such mechanisms are implicated in the pathogenesis of metabolic syndrome and inflammatory diseases .​ Yes, fructose, high-fructose corn syrup and the products made from it cause serious bowel diseases. Cardiac arrhythmias? Let's consider the rather remarkable increase in the number of patients presenting with atrial fibrillation, with no apparent precipitant cause. ' The number of 'Cardiac Ablations' done is remarkable, and most of them may be unnecessary, as reducing the intake of fructose and lowering the level of uric acid below the 5.5 level may be all that is required to correct the problem. Systemic Inflammatory Responses Consumption of fructose-rich diets has been shown to elevate levels of inflammatory markers, including C-reactive protein (CRP) and intercellular adhesion molecule-1 (ICAM-1). These markers are indicative of endothelial dysfunction and heightened inflammatory states, contributing to the development and progression of chronic inflammatory conditions . Impact on Insulin Resistance and Obesity At best, Fructose will make you fat. The Insulin resistance and liver damage will eventually catch up with you. Fructose consumption is linked to insulin resistance through mechanisms involving increased hepatic gluconeogenesis and lipid accumulation. Insulin resistance itself is a pro-inflammatory state, contributing to the pathophysiology of type 2 diabetes and obesity. Obesity further exacerbates inflammation due to adipose tissue's role in secreting pro-inflammatory cytokines .​ Conclusion Excessive dietary fructose contributes to the pathogenesis of arthritis and other inflammatory conditions through multiple mechanisms, including increased uric acid production, promotion of gut dysbiosis, induction of systemic inflammatory responses, and exacerbation of insulin resistance and obesity. Limiting fructose intake may be beneficial in mitigating these inflammatory processes and improving overall health outcomes.​ Stop eating yourself to death. More so, Fructose directly causes the skin to age prematurely, but more on that, later! References Baharuddin B. The Impact of Fructose Consumption on Human Health: Effects on Obesity, Hyperglycemia, Diabetes, Uric Acid, and Oxidative Stress With a Focus on the Liver. Cureus . 2024;16(9):e70095. Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation. Biomedicines . 2021;9(7):728. ​ Fructose Induces the Inflammatory Molecule ICAM-1 in Endothelial Cells. Journal of the American Society of Nephrology . 2008;19(9):1712-1720.​ PMC High-Fructose Diet Increases Inflammatory Cytokines and Alters Gut Microbiota Composition in Rats: A Pilot Study. BioMed Research International . 2020;2020:6672636.​ Chung M, Ma J, Patel K, Berger S, Lau J. Fructose, High-Fructose Corn Syrup, Sucrose, and Nonalcoholic Fatty Liver Disease or Indexes of Liver Health: A Systematic Review and Meta-Analysis. The American Journal of Clinical Nutrition . 2014;100(3):833-849. Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M. Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease. Journal of Hepatology . 2018;68(5):1063-1075.​ White JS. Misconceptions about High-Fructose Corn Syrup: Is It Uniquely Responsible for Obesity, Reactive Dicarbonyl Compounds, and Advanced Glycation Endproducts? Journal of Nutrition . 2009;139(6):1219S-1227S. Dufault R. Mercury from Chlor-Alkali Plants: Measured Concentrations in Food Product Sugar. Environmental Health . 2009;8:2.​ Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Down to Basics comes in preparations with and without Iron. Taken 2 capsules twice daily. In our journey towards better health, many people turn to multivitamin and mineral supplements to bridge nutritional gaps. While a balanced diet is ideal, various factors—like busy lifestyles and dietary restrictions—can make it hard to get all the necessary nutrients. Not every multivitamin is created equal, though. This article breaks down the key vitamins and minerals to look for when selecting a top-quality multivitamin and mineral supplement. Understanding the Basics of Multivitamins Multivitamins are dietary supplements that combine various vitamins and minerals, sometimes with additional nutrients. They aim to cover nutrients that might be lacking in our diets. The make-up of a multivitamin can vary widely. It is essential to know which vitamins and minerals are crucial for your overall health and well-being. There is only so much space in a tablet or capsule. To get all that you need, it almost always requires multiple tablets and/or capsules to accomplish this. A marketing trick that is often used in making a 'single-tablet per day' solution is to use what is called " A Sprinkle ," which is to put just enough of the moiety to give them a line on the ingredients list. As you know, treatment and prevention of disease requires a threshold therapeutic dosage. If a product were to contain all of the vitamins that you need it may take two or more capsules. Minerals can be in a bio-available format, or chelate, or it can be provided as an inorganic salt. The inorganic salts are smaller molecules, packing more tightly but delivering little therapeutic benefit. This is the most common of the tricks used, as it looks like you are getting something with fewer tablets or capsules, when in fact, you are getting little to nothing for your money. Conceptually, what is done is the equivalent of claiming that they put a quart of water 'packed into a pint bottle.' Key Vitamins to Look For Vitamin A Vitamin A is vital for healthy vision, immune response, and skin condition. This fat-soluble vitamin exists in two forms: retinol, derived from animal products, and provitamin A carotenoids, found in plant sources like carrots and sweet potatoes. When choosing a multivitamin, aim for a balance of these two forms. For instance, one serving of cooked carrots provides about 109% of the daily requirement for carotenoids. Retinol, on the other hand, is available in liver and dairy products. B Vitamins The B-complex vitamins are critical for energy production, brain health, and red blood cell formation. A complete B vitamin complex most often includes: B1 (Thiamine): Supports energy metabolism. B2 (Riboflavin): Aids in energy production and cell function. B3 (Niacin): Elevates cholesterol levels and improves skin health. B5 (Pantothenic acid): Necessary for fatty acid synthesis. B6 (Pyridoxine): Important for protein metabolism. B7 (Biotin): Enhances hair and nail health. B9 (Folic acid): Crucial for cell division, especially during pregnancy. B12 (Cobalamin): Essential for nerve function and blood production. Select a multivitamin that offers a full spectrum of these vitamins. Research shows that B vitamins work together effectively in the body, and a deficiency in one can affect others. Vitamin C Vitamin C is a powerful antioxidant that boosts the immune system and improves iron absorption. It also helps synthesize collagen, which is vital for skin integrity. High-quality multivitamins should contain at least 60 mg of vitamin C, which is about 67% of the daily recommended intake for adults. Vitamin D-3 Often referred to as the "sunshine vitamin," vitamin D is crucial for bone health and helps with calcium absorption. It also plays a role in supporting the immune system. A significant number of people experience vitamin D deficiency, particularly those who spend limited time outdoors. An effective multivitamin should provide at the very least 800 IU of vitamin D3 (cholecalciferol.) Vitamin D-2 is not the active moiety, and must be converted to Vitamin D-3 by sunlight. We all know how unhealthy sunlight is for the skin. ( Much more on Vitamin D-3, in following Blogs ) Vitamin E This vitamin acts as a potent antioxidant, safeguarding cells from oxidative damage. It is key to maintaining skin and eye health while supporting immune function. When choosing a multivitamin, look for natural forms like d-alpha-tocopherol. ( More on Vitamin E in following Blogs ) Vitamin Preferred/Bioavailable Forms Notes Vitamin A Retinyl palmitate + beta-carotene Mixed forms help avoid toxicity and support antioxidant activity Vitamin C Ascorbic acid or buffered ascorbates (e.g., calcium ascorbate) Buffered forms reduce GI irritation Vitamin D Cholecalciferol (D3) D3 is more effective than D2 in raising serum 25(OH)D Vitamin E Mixed tocopherols and tocotrienols Not just alpha-tocopherol; balance enhances antioxidant function Vitamin K K1 (phylloquinone) + K2 (menaquinone-7) K2 is especially important for calcium regulation B Vitamins Methylated/active forms: methylcobalamin (B12), P-5-P (B6), methylfolate (B9) Avoid folic acid and cyanocobalamin if possible—active forms bypass common polymorphisms Biotin (B7) Standard form is acceptable Important for metabolic and skin/hair support Pantothenic Acid (B5) Calcium pantothenate or pantethine Essential for adrenal and energy support 2. Essential Minerals (in chelated or bioavailable forms) Essential Minerals Calcium Calcium is paramount for strong bones and teeth, and it also supports muscle function. Multivitamins should ideally contain around 500 mg of calcium, and twice that amount for women at risk of osteoporosis. Magnesium Magnesium is involved in over 300 bodily functions , including energy production and muscle contractions. It also has calming effects. A high-quality multivitamin should include magnesium in a form that is easily absorbed, such as magnesium glycinate, malate, threonate or taurate, which have been shown to have higher bioavailability rates. Zinc Zinc is vital for immune health and wound healing. It supports DNA synthesis and cell division. A multivitamin should contain at least 11 mg of zinc, as too little can make one more susceptible to infections. Too much zinc can cause problems. Never use the nasal inhalational zinc preparations, as they can cause permanent nerve damage to your ability to smell or taste. Iron Iron is essential for producing hemoglobin, which transports oxygen in the blood. Women generally need more iron than men due to menstruation. High-quality multivitamins should offer iron in forms like ferrous bisglycinate, which is known for being readily absorbed and gentle on the stomach. Selenium Selenium acts as an antioxidant and supports thyroid and immune function. A sufficient dose of selenium in a multivitamin, can help combat oxidative stress and enhance immune defense, and it is essential to thyroid health. Care must be taken with selenium, and I generally do not recognize using it as a single mineral product due to safety concerns. Vanadium, Boron, Manganese and a variety of other micronutrients Mineral Preferred Forms Notes Calcium Citrate, malate, or MCHA (microcrystalline hydroxyapatite) Avoid carbonate unless paired with food; lower doses preferred in multivitamins Magnesium Glycinate, malate, citrate Oxide has poor absorption; glycinate is gentle on GI Zinc Picolinate, citrate, bisglycinate Zinc balance with copper is critical Copper Bisglycinate, gluconate Avoid excess; essential for antioxidant enzymes Selenium Selenomethionine Well-absorbed; supports thyroid and immune function Chromium Picolinate or polynicotinate Important in glucose metabolism Manganese Citrate, bisglycinate Cofactor in many enzymatic systems Molybdenum Glycinate Rarely discussed but necessary for detox enzyme pathways Iodine Potassium iodide or kelp (standardized) Supports thyroid health; too much can be detrimental Down to Basics Without Iron. Very comprehensive, very inexpensive to use. Note that the daily dosage is 4 capsules to get this done. Taken 2 mornings and 2 evenings, with food. Additional Nutrients, Generally Taken in Combination with the Multivitamin Product Beyond the essential vitamins and minerals, there are other nutrients that can boost a multivitamin’s effectiveness: Omega-3 Fatty Acids, EPA, DHA, ALA Often excluded from traditional multivitamins, omega-3 fatty acids are essential for heart and brain wellness. Supplements sourced from fish oil or algae provide added health benefits, with studies showing they can reduce the risk of heart disease by up to 30%. Coenzyme Q10 CoQ10 supports energy production in cells and contributes to heart health. Including CoQ10 in a multivitamin can enhance cardiovascular support, especially in those concerned about heart-related issues. Probiotics Probiotics aid gut health and support the immune system. A multivitamin that includes probiotic strains can facilitate better digestion and nutrient absorption. Antioxidants Adding antioxidants like lutein and zeaxanthin can enhance a multivitamin's benefits. They help combat oxidative damage and support overall well-being. Antioxidants are not interchangeable. Each works on a specific tissue or organ or combination of tissues and organs. One is not necessarily better than the rest, as a combination of anti-oxidants is generally needed. The Importance of Bioavailability When selecting a multivitamin, consider the bioavailability of its nutrients. This term refers to how effectively the body can absorb and utilize a nutrient. Many supplements include synthetic forms or those that are poorly absorbed. Superior products tend to use high-quality and bioavailable forms of nutrients. Check labels for clarity on the forms of nutrients to ensure you are making an informed decision. Tailoring to Specific Needs Not everyone needs the same multivitamin. Different groups have unique nutritional requirements: Women of Reproductive Age: May benefit from higher folic acid and iron levels to support reproductive health. Pregnant Women: Should look for multivitamins with extra folate (400 mcg) and DHA. Older Adults: May require increased levels of vitamin D (800 IU), B12 (2.4 mcg), and calcium (1,200 mg). Athletes: Often need extra vitamins and minerals to support energy production and recovery. Choosing a tailored multivitamin can ensure these needs are met for optimal health. Potential Risks of Overconsumption While multivitamins are beneficial, taking excessive amounts can lead to toxicity. Fat-soluble vitamins (A, E, and K) can accumulate in the body and cause harm if not managed properly. Before starting any supplement, especially for pregnant or nursing mothers or individuals with specific health concerns, consult a healthcare professional. Making the Right Choice for Your Health Choosing a multivitamin and mineral supplement involves understanding which essential vitamins and minerals are necessary for your health. A top-quality multivitamin should list a range of nutrients, prioritize bioavailability, and cater to individual needs. As you explore ways to support your health through supplementation, focus on quality ingredients and informed choices. This knowledge will help pave the way for achieving optimal well-being. Generally speaking, the older you are, the greater the mineral needs become. In my patient population, I tailor the additional nutraceuticals based on age, gender, disease state and performance needs. I start with Down to Basics (with/without) Iron. The 'with iron' product is used in females of menstrual age or if anemia is present. Two capsules twice daily with food. For patients over 50 years of age, I add 1 capsule twice daily to the regular dosage of Down to Basics To that, I may add 'Magic Minerals,' one capsule twice daily to ensure an adequate amount of zinc, selenium, vanadium and chromium. For patients with insulin resistance, diabetes or pre-diabetes, I add Diabet Stat, 1 capsule twice daily to the regimen. If a patient is diabetic, insulin resistant or obese, I will add 'Diabet Stat,' one capsule twice daily to lower blood sugar, lower insulin and reduce weight. Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician

Magnesium is an essential mineral that plays a vital role in many bodily functions. It helps with muscle and nerve function, regulates blood sugar, and controls blood pressure. With more people learning about its health benefits, magnesium products are gaining popularity. In this post, we will look at various types of magnesium supplements, highlighting their advantages and disadvantages to help you make informed choices about which one might be right for you. In the context of nutrition, a 'mineral' is an elemental substance, an inorganic moiety that joins with a protein as an enzyme cofactor or as a structural portion of the protein. As an enzyme co-factor, it is thought that magnesium participates as an essential component in over 300, perhaps as many as 400 different chemical processes in the body, essential to life and health. Deficiencies in magnesium, ranging from mild to profound, have a remarkably variable set of symptoms, but a simple blood study can shed light on a person's 'magnesium status.' Magnesium deficiency may be the most prevalent of the nutritional deficiency states, but it is by no means the only one. For most persons, it is most practical to use a thoughtful mixture of magnesium chelates, as they subtly differ in over all absorption and collateral benefits. This is a balanced mineral chelate, created as a maintenance product. It is remarkably inexpensive and yet provides the largest part of our daily mineral needs. Why are so many of us magnesium deficient? Magnesium deficiency may be a problem in as many as 30% of the United States Population. Why is this? Magnesium is an element, and as such, it is neither created nor destroyed. It is either present in the soil in generous amounts, or it may be entirely deficient. The fruits and vegetables that we eat may not give us an adequate amount of magnesium as it was not in the soil in generous concentrations, therefor the plants that we eat will not deliver us this nutrient. Magnesium deficiency is extremely common. When it comes to magnesium chelates, you much choose intelligently and wisely. If Magnesium is not in the soil, it will not make it into your digestive tract. Much of our farmland has found itself depleted of micronutrients, and this leads us to the question: "Why do we need to supplement our food with vitamins, minerals and such?" The food that we eat is harvested from fields that are largely deficient in a variety of micronutrients. The fun begins with understanding the problem and then choosing the most effective and affordable approach to correcting the deficiency. Again, selection is based on desired 'side-effect.' As an example, "Sedation is a problem for one person, it is a sleep medicine for the next. Constipation might be reasonable for one person, but loose stools may be desired for the next." Types of Magnesium Chelates from which to choose 1. Magnesium Citrate Magnesium citrate is among the most common magnesium supplements. It's formed by combining magnesium with citric acid, which may enhance absorption in the body. Best used to treat constipation, Magnesium Citrate has been used for years as part of Colon Preparations for colonoscopy and bowel surgery. This form is particularly known for its laxative effects, making it beneficial for those facing constipation. While this is helpful, it may not suit individuals who do not require this effect. Additionally, magnesium citrate can also improve sleep quality and aid muscle relaxation. In fact, 70% of users report better sleep after taking it. Over all, Magnesium Citrate is best used as a laxative , and not as a supplemental source of Magnesium. Advantages High Absorption Rate : Its bioavailability means your body absorbs it more effectively than some other forms. Magnesium Citrate is very, very cheap. Disadvantages Potential Diarrhea : Some people may experience diarrhea or discomfort due to its laxative properties. Taste : The flavor might be unappealing to some users , making it harder to incorporate into their routine. 2. Magnesium Glycinate Magnesium glycinate is made by combining magnesium with glycine, an amino acid known for calming effects. Magnesium glycinate , magnesium malate and magnesium taurate in a balanced mixture. This is our 'go-to' product for additional magnesium supplementation. This form is highly bioavailable and gentle on the stomach, appealing to those with digestive sensitivities. Advantages Calm and Relaxation : Users claim it reduces anxiety, helping to improve sleep quality . For example, a study reported that 80% of participants felt less anxious after taking magnesium glycinate. Gentle on Stomach : It is less likely to irritate the digestive system compared to other forms. Better Absorption : Glycine enhances its absorption, making it effective even in smaller doses. Disadvantages Cost : It tends to be pricier than other types of magnesium supplements. Overdose Risk : Large doses can still cause stomach issues, though this is less common. Follow instructions , Magnesium Glycinate is the over-all best choice in Magnesium Chelates for the vast majority of patients. 3. Magnesium Oxide Magnesium oxide is one of the most widely available forms . It combines magnesium with oxygen and offers a high magnesium content per dose. For most people, it is a simple waste of money at best, and at worst, it blocks the uptake of other nutrients. However, its absorption rate is lower than that of citrate or glycinate, which may limit its effectiveness. Magnesium Oxide is essentially 'magnesium rust.' This is the cheapest magnesium and it is found in the 'low end' vitamin and mineral supplements. Advantages It is cheap. Disadvantages Lower Absorption : It has less bioavailability, making it potentially less effective for some people. Gastrointestinal Issues : There may still be digestive discomfort, including cramping, and loose bowel movements. 4. Magnesium Malate Sometimes it is easier and acceptable to use a vitamin/mineral combination. Understand that it is impossible to pound an adult dosage into a single 'once daily' tablet or capsule. This product must be taken 2 capsules twice daily to 'get what you need.' Magnesium malate combines magnesium with malic acid, which is known to support energy production. Advantages Energy Production : Research shows it may enhance energy metabolism, making it particularly beneficial for individuals suffering from fatigue, with some reporting an energy boost of up to 50%. Gentle on the Stomach : Magnesium malate is generally well tolerated and has fewer digestive issues. Muscle Function : It may support muscle recovery, which can be particularly helpful after workouts. This is the best choice for magnesium supplementation in the patient with fibromyalgia or other muscular disorders. Disadvantages Taste : It may not have the best flavor, similar to magnesium citrate. Limited Availability : It might not be as readily found in all stores compared to more common types. 5. Magnesium Taurate Magnesium taurate pairs magnesium with taurine, an amino acid beneficial for heart health. Advantages Heart Health : This form may help in maintaining healthy blood pressure and overall cardiovascular wellness, with studies showing reductions of up to 10% in some cases. Calming Effects : Taurine can offer additional calming benefits, which may help alleviate anxiety symptoms. Well-Absorbed : It is generally well-absorbed by the body. Disadvantages Higher Cost : Combining magnesium with taurine can raise the price. Less Common : This form may be tougher to find in ordinary retail stores. Advantages of Magnesium Threonate If cognitive dysfunction is part of the clinical presentation, we will add two capsules of this product to the daily regimen. It is not used for routine preventive nutritional supplementation. Enhanced CNS Penetration: Magnesium L-threonate is distinguished by its superior ability to cross the blood–brain barrier. This was demonstrated in preclinical studies (e.g., Li et al., Neuron , 2010), which showed significant elevation of brain magnesium levels compared to other magnesium salts. This is particularly relevant since CNS magnesium concentration appears to correlate with synaptic plasticity and cognitive performance. Cognitive Benefits: Preliminary animal and limited human data suggest it may enhance working memory, learning, and executive function—especially in aging populations. A 2016 human study ( Liu et al. , J Alzheimers Dis ) found that magnesium L-threonate improved cognitive measures in older adults with mild cognitive impairment over a 12-week period. Neuroprotective Potential: Animal studies have shown effects on synaptic density and long-term potentiation (LTP), possibly offering protective effects against neurodegenerative processes. Reduced Gastrointestinal Distress: Compared to other magnesium forms (e.g., oxide, citrate), L-threonate tends to be better tolerated gastrointestinally, with a lower incidence of diarrhea or cramping. Disadvantages of Magnesium Threonate Cost and Accessibility: It is significantly more expensive than standard forms of magnesium such as glycinate, citrate, or oxide, making it less accessible for long-term use. Limited Magnesium Content: Magnesium L-threonate provides a relatively low elemental magnesium yield per dose (~7–10%), meaning higher doses are required to match the systemic repletion effects of other salts. Sparse Clinical Evidence: While promising, human studies remain sparse and often industry-funded. Larger, long-term, independently-funded RCTs are lacking. The enthusiasm is largely extrapolated from rodent studies and limited human trials. Uncertain Effects on Systemic Magnesium Deficiency: It may not be the ideal choice for addressing frank systemic hypomagnesemia (e.g., in cardiovascular or metabolic disorders) , given its low elemental magnesium and CNS-targeted absorption. It is best used in addition to a magnesium glycinate/taurate/malate product, essentially as a source of Threonine (beneficial in the treatment of age-related cognitive dysfunction, memory issues and dementia. Potential for Overstated Claims: Due to its novelty and market positioning as a “brain supplement,” some claims around its nootropic effects may outpace current empirical support. That is, keep an 'open mind,' as anecdotal reports observe beneficial response in a significant number of patients being given this supplement. Conclusion Magnesium L-threonate holds potential as a CNS-targeted magnesium supplement, particularly in contexts where cognitive support or neuroprotection is the aim. However, for general magnesium repletion or metabolic support, more cost-effective and well-studied alternatives may be preferable. Choosing the Right Magnesium Chelate. Choose intelligently. When selecting the right magnesium product, consider your health goals and how your body responds. Here are a few tips: Health Goals : Identify your main reason for taking magnesium. If relaxation and sleep are your goals, magnesium glycinate might be ideal. For energy support, magnesium malate could be more suitable. Digestive Sensitivity : If you've experienced stomach issues with other forms, opt for magnesium glycinate or malate. Budget : If cost matters, magnesium oxide is usually the most affordable option, even if it provides the poorest quality option. Availability : Make sure to check local stores or online options, as some forms may be less accessible. Final Thoughts Magnesium plays a crucial role in maintaining health and wellness. With various forms available, each with unique benefits and drawbacks, it is essential to research before making your choice. Whether you want to improve sleep, energy levels, or digestive health, there is a magnesium supplement that can help. Always consult a healthcare professional before starting any new supplement to ensure it aligns with your health needs and medication interactions. By understanding magnesium products better, you can make proactive choices that positively impact your health and overall well-being. References: Walker, A. F., Marakis, G., Christie, S., & Byng, M. (2003). Magnesium supplementation alleviates premenstrual symptoms of fluid retention. Journal of Women's Health & Gender-Based Medicine , 12(4), 389-397.  This study demonstrated that magnesium supplementation, particularly in chelated forms, effectively reduced premenstrual fluid retention symptoms.​ Rosanoff, A., Weaver, C. M., & Rude, R. K. (2012). Suboptimal magnesium status in the United States: Are the health consequences underestimated? Nutrition Reviews , 70(3), 153-164.  The authors discuss the prevalence of magnesium deficiency and highlight the superior absorption of magnesium chelates over inorganic salts.​ Coudray, C., Rambeau, M., Feillet-Coudray, C., Tressol, J. C., Demigné, C., Gueux, E., & Rayssiguier, Y. (2005). Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnesium Research , 18(4), 215-223.  This research compared the bioavailability of various magnesium salts, finding that organic chelates had higher absorption rates.​ Lindberg, J. S., Zobitz, M. M., Poindexter, J. R., & Pak, C. Y. (1990). Magnesium bioavailability from magnesium citrate and magnesium oxide. Journal of the American College of Nutrition , 9(1), 48-55.  The study concluded that magnesium citrate, an organic chelate, has superior bioavailability compared to magnesium oxide.​ Schuette, S. A., Lashner, B. A., & Janghorbani, M. (1994). Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. Journal of Parenteral and Enteral Nutrition , 18(5), 430-435.  This clinical trial demonstrated that magnesium diglycinate, a chelated form, had better absorption in patients with compromised intestinal function.​ Firoz, M., & Graber, M. (2001). Bioavailability of US commercial magnesium preparations. Magnesium Research , 14(4), 257-262.  The authors evaluated various magnesium supplements and found that chelated forms had higher bioavailability.​ Ranade, V. V., & Somberg, J. C. (2001). Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. American Journal of Therapeutics , 8(5), 345-357.  This review highlights the enhanced bioavailability of magnesium chelates compared to inorganic salts.​ Altura, B. M., & Altura, B. T. (1999). Association of magnesium and calcium deficiencies with cardiovascular disease: The magnesium hypothesis revisited. Journal of the American College of Nutrition , 18(3), 240-246.  The paper discusses the role of magnesium, particularly in bioavailable forms like chelates, in cardiovascular health.​ Sabatini, S., & De Sole, P. (2008). Magnesium and osteoporosis: Current state of knowledge and future research directions. World Journal of Orthopedics , 9(3), 65-76.  The authors review the importance of magnesium, especially chelated forms, in bone health and osteoporosis prevention.​ Rude, R. K., Gruber, H. E., & Wei, L. Y. (2006). Magnesium deficiency: Effect on bone and mineral metabolism in the mouse. Calcified Tissue International , 79(4), 255-261.  This study indicates that magnesium deficiency adversely affects bone health and suggests that chelated supplements may be beneficial.​ Abbasi, B., Kimiagar, M., Sadeghniiat, K., Shirazi, M. M., Hedayati, M., & Rashidkhani, B. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences , 17(12), 1161-1169.  The trial found that magnesium supplementation, particularly in bioavailable forms, improved sleep quality in elderly individuals. Barbagallo, M., & Dominguez, L. J. (2010). Magnesium and aging. Current Pharmaceutical Design , 16(7), 832-839.  The authors discuss the role of magnesium, especially chelated forms, in mitigating age-related health issues.​ Mason, B. A., & Weaver, C. M. (2002). Magnesium supplementation and blood pressure in borderline hypertensive subjects: A pilot study. Journal of the American College of Nutrition , 21(1), 44-48.  This pilot study suggests that magnesium chelate supplementation may help in managing borderline hypertension.​ Guerrera, M. P., Volpe, S. L., & Mao, J. J. (2009). Therapeutic uses of magnesium. American Family Physician , 80(2), 157-162.  The article reviews various therapeutic applications of magnesium, highlighting the efficacy of chelated forms.​ Schwalfenberg, G. K., & Genuis, S. J. (2017). The importance of magnesium in clinical healthcare. Scientifica , 2017, 4179326.  The review emphasizes the clinical significance of magnesium and the superior absorption of chelated supplements.​ Rosanoff, A. (2010). Rising Ca:Mg intake ratio from food in USA adults: A concern? Magnesium Research , 23(4), S181-S193.  The paper discusses dietary imbalances and suggests chelated magnesium supplements as a corrective measure. Subscribe to our Blog   Dr Klein's Facebook Page https://www.facebook.com/stagesoflifemedicalinstitute David S. Klein, MD FACA FACPM David S. Klein, MD, FACA, FACPM 1917 Boothe Circle, Suite 171 Longwood, Florida 32750 Tel: 407-679-3337 Fax: 407-678-7246 www.suffernomore.com David S. Klein, MD Functional Medicine Physician